Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 1
2007 1
2008 1
2009 1
2010 3
2011 4
2012 2
2013 2
2014 1
2015 1
2016 4
2017 3
2018 10
2019 13
2020 19
2021 18
2022 19
2023 13
2024 30
2025 23
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Garakani A, et al. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020. Front Psychiatry. 2020. PMID: 33424664 Free PMC article. Review.
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. ...Posttraumatic stress disorder and obsessive-compulsive disorder are excluded from this review. Second, we will review novel pharmacotherapeutic agents …
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. ...Posttraumatic stress d …
Cannabis and Mental Health: A Review.
Kansagara D, Terry GE, Ayers CK, D'Souza DC. Kansagara D, et al. JAMA Intern Med. 2026 May 1;186(5):618-628. doi: 10.1001/jamainternmed.2025.8215. JAMA Intern Med. 2026. PMID: 41801216 Review.
These risks include worsening mania symptoms and function in those with bipolar disorder and an increase in psychotic symptoms in those with psychotic spectrum disorders. ...Regular use of high THC-content products by adolescents and young adults is associated with …
These risks include worsening mania symptoms and function in those with bipolar disorder and an increase in psychotic symptoms in tho …
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Strzelczyk A, Schubert-Bast S. Strzelczyk A, et al. CNS Drugs. 2022 Oct;36(10):1079-1111. doi: 10.1007/s40263-022-00955-9. Epub 2022 Oct 4. CNS Drugs. 2022. PMID: 36194365 Free PMC article. Review.
The latter include intellectual disability, developmental delay, behavioural problems including attention-deficit hyperactivity disorder and autism spectrum disorder, psychiatric problems including anxiety and depression, speech impairment and sleep problems. ...We …
The latter include intellectual disability, developmental delay, behavioural problems including attention-deficit hyperactivity disorder …
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits.
Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W. Hoch E, et al. Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):281-292. doi: 10.1007/s00406-024-01880-2. Epub 2024 Sep 19. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 39299947 Free PMC article. Review.
Chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and young adults, such as, disrupted learning, impaired cognitive performance, reduced educational attainment and an increased risk of CUD, psycho …
Chronic patterns of cannabis use have been associated with multiple adverse outcomes that are of particular concern among adolescents and yo …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Sarris J, et al. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
METHODS: The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted. Current evidence regarding whole plant formulations and plant-derived cannabinoid isolates in mood, anxiety, …
METHODS: The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric diso …
Cannabidiol as a Treatment for Mood Disorders: A Systematic Review.
Pinto JV, Saraf G, Frysch C, Vigo D, Keramatian K, Chakrabarty T, Lam RW, Kauer-Sant'Anna M, Yatham LN. Pinto JV, et al. Can J Psychiatry. 2020 Apr;65(4):213-227. doi: 10.1177/0706743719895195. Epub 2019 Dec 13. Can J Psychiatry. 2020. PMID: 31830820 Free PMC article.
Pharmacotherapies for cannabis use disorder.
Spiga F, Parkhouse T, Tang VM, Savović J, Le Foll B, Nielsen S. Spiga F, et al. Cochrane Database Syst Rev. 2025 Sep 30;9(9):CD008940. doi: 10.1002/14651858.CD008940.pub4. Cochrane Database Syst Rev. 2025. PMID: 41025421
Five studies targeted participants with comorbidities (depression (2), bipolar disorder (1), and attention deficit hyperactivity disorder (1)). Eleven studies received study medicines from the manufacturing company and none were funded by pharmaceutical companies. . …
Five studies targeted participants with comorbidities (depression (2), bipolar disorder (1), and attention deficit hyperactivity d …
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis.
Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Gobbi G, et al. JAMA Psychiatry. 2019 Apr 1;76(4):426-434. doi: 10.1001/jamapsychiatry.2018.4500. JAMA Psychiatry. 2019. PMID: 30758486 Free PMC article.
While the impact of adolescent cannabis use on the development of psychosis has been investigated in depth, little is known about the impact of cannabis use on mood and suicidality in young adulthood. OBJECTIVE: To provide a summary estimate of the extent to which cannabis …
While the impact of adolescent cannabis use on the development of psychosis has been investigated in depth, little is known about the impact …
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Stanciu CN, Brunette MF, Teja N, Budney AJ. Stanciu CN, et al. Psychiatr Serv. 2021 Apr 1;72(4):429-436. doi: 10.1176/appi.ps.202000189. Epub 2021 Feb 3. Psychiatr Serv. 2021. PMID: 33530732 Free PMC article.
OBJECTIVE: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently affect mood and anxiety. In this systematic review, the authors summarize the design and results o …
OBJECTIVE: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), d …
Cannabinoids.
Grotenhermen F. Grotenhermen F. Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. doi: 10.2174/156800705774322111. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16266285 Review.
Properties of CB receptor agonists that are of therapeutic interest include analgesia, muscle relaxation, immunosuppression, anti-inflammation, antiallergic effects, improvement of mood, stimulation of appetite, antiemesis, lowering of intraocular pressure, bronchodilation …
Properties of CB receptor agonists that are of therapeutic interest include analgesia, muscle relaxation, immunosuppression, anti-inflammati …
151 results